Evidence map›Paper›PMID 40149020›Full record

Trial reportRadiation oncology (London, England)2025

Innovative applications of visualized thermosensitive color-changing personalized boluses in post-mastectomy radiotherapy: a dosimetric analysis.

Yong Wang, Fujing Huang, Wenmin Han, Jianjun Qian, Peifeng Zhao, Liesong Chen, Yaqun Zhu, Ye Tian, Yanze Sun

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Radiation oncology (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yong Wang *Department of Radiotherapy Oncology, the Second Affiliated Hospital of Soochow University, Institute of Radiotherapy Oncology, Soochow University, Suzhou Key Laboratory for Radiation Oncology, Suzhou, 215004, China.
Fujing Huang *Affiliated Hospital, Shandong University of Traditional Chinese Medicine, Jinan, 250014, China.
Wenmin HanDepartment of Radiotherapy Oncology, the Second Affiliated Hospital of Soochow University, Institute of Radiotherapy Oncology, Soochow University, Suzhou Key Laboratory for Radiation Oncology, Suzhou, 215004, China.
Jianjun QianDepartment of Radiotherapy Oncology, the Second Affiliated Hospital of Soochow University, Institute of Radiotherapy Oncology, Soochow University, Suzhou Key Laboratory for Radiation Oncology, Suzhou, 215004, China.
Peifeng ZhaoDepartment of Radiotherapy Oncology, the Second Affiliated Hospital of Soochow University, Institute of Radiotherapy Oncology, Soochow University, Suzhou Key Laboratory for Radiation Oncology, Suzhou, 215004, China.
Liesong ChenDepartment of Radiotherapy Oncology, the Second Affiliated Hospital of Soochow University, Institute of Radiotherapy Oncology, Soochow University, Suzhou Key Laboratory for Radiation Oncology, Suzhou, 215004, China.
Yaqun ZhuDepartment of Radiotherapy Oncology, the Second Affiliated Hospital of Soochow University, Institute of Radiotherapy Oncology, Soochow University, Suzhou Key Laboratory for Radiation Oncology, Suzhou, 215004, China.
Ye TianDepartment of Radiotherapy Oncology, the Second Affiliated Hospital of Soochow University, Institute of Radiotherapy Oncology, Soochow University, Suzhou Key Laboratory for Radiation Oncology, Suzhou, 215004, China.
Yanze SunDepartment of Radiotherapy Oncology, the Second Affiliated Hospital of Soochow University, Institute of Radiotherapy Oncology, Soochow University, Suzhou Key Laboratory for Radiation Oncology, Suzhou, 215004, China. syzkk0109@163.com.

Funding

The Suzhou Science and Technology Program (Medical and Health Technology Innovation) Project SKY2022167)
6 · The paper itself

Abstract

background and purposeTo explore the feasibility and advantages of the visualized thermosensitive color-changing personalized bolus in post-mastectomy radiotherapy (PMRT). MATERIALS AND

methodsForty PMRT patients (June 2023-June 2024) were randomized into two groups. Group A (experimental group, 20 patients) underwent two CT scans: A

resultsIn Group A, A

conclusionsThe visualized thermosensitive color-changing personalized bolus demonstrated superior skin adherence, smaller air gaps, and better positional reproducibility compared to commercial boluses. Its dosimetric performance was consistent with virtual bolus plans, ensuring target coverage and OAR protection without increased skin toxicity. These findings support its clinical application in PMRT.

Indexed as

Breast NeoplasmsMastectomyRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedAdultAgedColorFemaleHumansMiddle AgedOrgans at RiskPrecision MedicineRadiometryRadiotherapy DosageTomography, X-Ray ComputedBolusBreast CancerColor-changingPost-Mastectomy radiotherapyThermosensitive

Identifiers

PMID40149020
PMCPMC11948852

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.